Role of serum biomarkers in early detection of diabetic cardiomyopathy in the West Virginian population

International Journal of Medical Sciences

Volumn 13, Issue 3, 2016, Pages 161-168

  Shaver, Adam ^a   Nichols, Alexandra ^a   Thompson, Ellen ^b   Mallick, Amrita ^a   Payne, Kristen ^a   Jones, Chris ^b   Manne, Nandini D P K ^b   Sundaram, Shanmuga ^a   Shapiro, Joseph I ^a   Sodhi, Komal ^b  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MARSHALL UNIVERSITY   (United States)

Author keywords

Cardiomyopathy; Diabetes; Serum biomarkers; West virginia

Indexed keywords

ADIPONECTIN; BILIRUBIN; BIOLOGICAL MARKER; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 7; INTERLEUKIN 6; ISOPROSTANE DERIVATIVE; LEPTIN; SOMATOMEDIN BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADIPOQ PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-RELATED PROTEIN 1; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; DISEASE COURSE; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN DETERMINATION; UNITED STATES; BLOOD; CASE CONTROL STUDY; DIABETIC CARDIOMYOPATHIES; ELECTROCARDIOGRAPHY; WEST VIRGINIA;

ADIPONECTIN; BILIRUBIN; BIOMARKERS; CASE-CONTROL STUDIES; DIABETIC CARDIOMYOPATHIES; ELECTROCARDIOGRAPHY; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INTERLEUKIN-6; ISOPROSTANES; LEPTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; WEST VIRGINIA;

EID: 84975722584     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.14141     Document Type: Article

References (39)

1. Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. The American journal of medicine. 2008; 121: 748-57. doi:10.1016/j.amjmed.2008.03.046.
2. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007; 115: 3213-23. doi:10.1161/CIRCULATIONAHA.106.679597.
3. Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ, et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. Journal of the American College of Cardiology. 2003; 42: 328-35.
4. From AM, Scott CG, Chen HH. The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. Journal of the American College of Cardiology. 2010; 55: 300-5. doi:10.1016/j.jacc.2009.12.003.
5. Jagasia D, McNulty PH. Diabetes mellitus and heart failure. Congestive heart failure. 2003; 9: 133-9; quiz 40-1.
6. Miki T, Yuda S, Kouzu H, Miura T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart failure reviews. 2013; 18: 149-66. doi:10.1007/s10741-012-9313-3.
7. Lam CS. Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction. Diabetes & vascular disease research. 2015. doi:10.1177/1479164115579006.
8. Stanley WC, Lopaschuk GD, McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovascular research. 1997; 34: 25-33.
9. Carley AN, Severson DL. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochimica et biophysica acta. 2005; 1734: 112-26. doi:10.1016/j.bbalip.2005.03.005.
10. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2004; 18: 1692-700. doi:10.1096/fj.04-2263com.
11. McGavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R, et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation. 2007; 116: 1170-5. doi:10.1161/CIRCULATIONAHA.106.645614.
12. Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X, et al. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. Journal of the American College of Cardiology. 2006; 48: 1688-97. doi:10.1016/j.jacc.2006.07.022.
13. Cai L. Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy. Free radical biology & medicine. 2006; 41: 851-61. doi:10.1016/j.freeradbiomed.2006.06.007.
14. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, et al. Myocardial cell death in human diabetes. Circulation research. 2000; 87: 1123-32.
15. Jay D, Hitomi H, Griendling KK. Oxidative stress and diabetic cardiovascular complications. Free radical biology & medicine. 2006; 40: 183-92. doi:10.1016/j.freeradbiomed.2005.06.018.
16. Haugen E, Chen J, Wikstrom J, Gronros J, Gan LM, Fu LX. Parallel gene expressions of IL-6 and BNP during cardiac hypertrophy complicated with diastolic dysfunction in spontaneously hypertensive rats. International journal of cardiology. 2007; 115: 24-8. doi:10.1016/j.ijcard.2006.01.031.
17. Liu T, Stern A, Roberts LJ, Morrow JD. The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid. Journal of biomedical science. 1999; 6: 226-35. doi:25391.
18. Liang Q, Carlson EC, Donthi RV, Kralik PM, Shen X, Epstein PN. Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes. 2002; 51: 174-81.
19. Matsushima S, Kinugawa S, Ide T, Matsusaka H, Inoue N, Ohta Y, et al. Overexpression of glutathione peroxidase attenuates myocardial remodeling and preserves diastolic function in diabetic heart. American journal of physiology Heart and circulatory physiology. 2006; 291: H2237-45. doi:10.1152/ajpheart.00427.2006.
20. Ye G, Metreveli NS, Donthi RV, Xia S, Xu M, Carlson EC, et al. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes. 2004; 53: 1336-43.
21. Shen X, Zheng S, Metreveli NS, Epstein PN. Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes. 2006; 55: 798-805.
22. Zhao Y, Zhang L, Qiao Y, Zhou X, Wu G, Wang L, et al. Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy. PloS one. 2013; 8: e75927. doi:10.1371/journal.pone.0075927.
23. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacological reviews. 2008; 60: 79-127. doi:10.1124/pr.107.07104.
24. Li J, Su S, Zong X. Analysis of the association between adiponectin, adiponectin receptor 1 and diabetic cardiomyopathy. Experimental and therapeutic medicine. 2014; 7: 1023-7. doi:10.3892/etm.2014.1539.
25. Issan Y, Kornowski R, Aravot D, Shainberg A, Laniado-Schwartzman M, Sodhi K, et al. Heme oxygenase-1 induction improves cardiac function following myocardial ischemia by reducing oxidative stress. PloS one. 2014; 9: e92246. doi:10.1371/journal.pone.0092246.
26. Asbun J, Villarreal FJ. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. Journal of the American College of Cardiology. 2006; 47: 693-700. doi:10.1016/j.jacc.2005.09.050.
27. Ruan W, Lai M. Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome? Acta diabetologica. 2010; 47: 5-14. doi:10.1007/s00592-009-0142-3.
28. Gandhi PU, Gaggin HK, Sheftel AD, Belcher AM, Weiner RB, Baggish AL, et al. Prognostic usefulness of insulin-like growth factor-binding protein 7 in heart failure with reduced ejection fraction: a novel biomarker of myocardial diastolic function? The American journal of cardiology. 2014; 114: 1543-9. doi:10.1016/j.amjcard.2014.08.018.
29. Iglesias-De La Cruz MC, Ruiz-Torres P, Alcami J, Diez-Marques L, Ortega-Velazquez R, Chen S, et al. Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney international. 2001; 59: 87-95. doi:10.1046/j.1523-1755.2001.00469.x.
30. Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY, et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation. 2001; 103: 102-7.
31. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography. 2009; 22: 107-33. doi:10.1016/j.echo.2008.11.023.
32. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. European journal of echocardiography: the journal of the Working Group on Echocardiography of the European Society of Cardiology. 2006; 7: 79-108. doi:10.1016/j.euje.2005.12.014.
33. Bays HE, Chapman RH, Grandy S, Group SI. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. International journal of clinical practice. 2007; 61: 737-47. doi:10.1111/j.1742-1241.2007.01336.x.
34. Sun M, Chen M, Dawood F, Zurawska U, Li JY, Parker T, et al. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation. 2007; 115: 1398-407. doi:10.1161/CIRCULATIONAHA.106.643585.
35. Ruhl CE, Harris TB, Ding J, Goodpaster BH, Kanaya AM, Kritchevsky SB, et al. Body mass index and serum leptin concentration independently estimate percentage body fat in older adults. The American journal of clinical nutrition. 2007; 85: 1121-6.
36. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nature medicine. 2004; 10: 1384-9. doi:10.1038/nm1137.
37. Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, Bui HH, et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nature medicine. 2011; 17: 55-63. doi:10.1038/nm.2277.
38. Battiprolu PK, Lopez-Crisosto C, Wang ZV, Nemchenko A, Lavandero S, Hill JA. Diabetic cardiomyopathy and metabolic remodeling of the heart. Life sciences. 2013; 92: 609-15. doi:10.1016/j.lfs.2012.10.011.
39. Guo XH, Liu LX, Zhang HY, Zhang QQ, Li Y, Tian XX, et al. Insulin-like growth factor binding protein-related protein 1 contributes to hepatic fibrogenesis. Journal of digestive diseases. 2014; 15: 202-10. doi:10.1111/1751-2980.12126.